These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1207 related items for PubMed ID: 20301541
21. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report. Vondrák K, Seeman T. Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469 [Abstract] [Full Text] [Related]
22. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Kashtan CE. ; 1993 Apr. PubMed ID: 20301386 [Abstract] [Full Text] [Related]
23. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens. Krishnappa V, Gupta M, Elrifai M, Moftakhar B, Ensley MJ, Vachharajani TJ, Sethi SK, Raina R. Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893 [Abstract] [Full Text] [Related]
24. Deleterious Impact of a Novel CFH Splice Site Variant in Atypical Hemolytic Uremic Syndrome. Schönauer R, Seidel A, Grohmann M, Lindner TH, Bergmann C, Halbritter J. Front Genet; 2019 Apr; 10():465. PubMed ID: 31156713 [Abstract] [Full Text] [Related]
25. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Loeys BL, Dietz HC. ; 1993 Apr. PubMed ID: 20301312 [Abstract] [Full Text] [Related]
26. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report. Xie L, Nester CM, Reed AI, Zhang Y, Smith RJ, Thomas CP. Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022 [Abstract] [Full Text] [Related]
35. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Sobacchi C, Villa A, Schulz A, Kornak U. ; 1993 Dec. PubMed ID: 20301306 [Abstract] [Full Text] [Related]
36. Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome. Bu F, Zhang Y, Wang K, Borsa NG, Jones MB, Taylor AO, Takanami E, Meyer NC, Frees K, Thomas CP, Nester C, Smith RJH. J Am Soc Nephrol; 2018 Dec; 29(12):2809-2819. PubMed ID: 30377230 [Abstract] [Full Text] [Related]
37. Variants in complement genes are uncommon in patients with anti-factor H autoantibody-associated atypical hemolytic uremic syndrome. Khandelwal P, Joshi A, Mathur A, Puraswani M, Gurjar BS, Sinha A, Hari P, Faruq M, Bagga A. Pediatr Nephrol; 2023 Aug; 38(8):2659-2668. PubMed ID: 36622444 [Abstract] [Full Text] [Related]
38. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation. Tran H, Chaudhuri A, Concepcion W, Grimm PC. Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349 [Abstract] [Full Text] [Related]
39. Complement Factor I Variants in Complement-Mediated Renal Diseases. Zhang Y, Goodfellow RX, Ghiringhelli Borsa N, Dunlop HC, Presti SA, Meyer NC, Shao D, Roberts SM, Jones MB, Pitcher GR, Taylor AO, Nester CM, Smith RJH. Front Immunol; 2022 Mar; 13():866330. PubMed ID: 35619721 [Abstract] [Full Text] [Related]
40. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Zhang K, Astigarraga I, Bryceson Y, Lehmberg K, Machowicz R, Marsh R, Sieni E, Wang Z, Nichols KE. ; 1993 Mar. PubMed ID: 20301617 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]